Endocrine-Based Treatments in Clinically-Relevant Subgroups of Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Systematic Review and Meta-Analysis
Immune system and angiogenesis‑related potential surrogate biomarkers of response to everolimus‑based treatment in hormone receptor‑positive breast cancer: an exploratory study
